Results 101 to 110 of about 400,521 (193)

Empagliflozin-induced liver injury

open access: yesEuropean Journal of Case Reports in Internal Medicine
Background: Drug-induced liver injury is an uncommon, idiosyncratic adverse reaction with heterogeneous clinical presentations, ranging from asymptomatic transaminase elevations to acute liver failure.
Hélder Diogo Gonçalves   +6 more
doaj   +1 more source

Drug-induced chronic liver injury [PDF]

open access: yesJournal of Hepatology, 2018
Lara, Dakhoul   +2 more
openaire   +2 more sources

Dicumarol [PDF]

open access: yes, 1945
Thesis (M.D.)--Boston ...
Steel, Robert MacDonald
core  

Role of metabolic nuclear receptors in acute liver injury and drug-induced hepatotoxicity

open access: yesPharmacological Research
Metabolic nuclear receptors (NRs) are ligand-activated transcription factors central to metabolic homeostasis and detoxification. While their roles in chronic liver diseases have been reviewed, comprehensive reviews specifically addressing the role of ...
Liangliang Nie   +4 more
doaj   +1 more source

Interferon-gamma inducible protein 10 (IP10) induced cisplatin resistance of HCC after liver transplantation through ER stress signaling pathway. [PDF]

open access: yes, 2015
Tumor recurrence remains an obstacle after liver surgery, especially in living donor liver transplantation (LDLT) for patients with hepatocellular carcinoma (HCC).
Geng, Wei   +9 more
core   +1 more source

Insights into the Biochemical and Immune Mechanisms in Drug-Induced Liver Injury Pathogenesis. [PDF]

open access: yesChem Res Toxicol
Saville E   +4 more
europepmc   +1 more source

A human liver organoids-on-chip for the assessment of drug-induced liver injury. [PDF]

open access: yesBMC Pharmacol Toxicol
Chen X   +6 more
europepmc   +1 more source

Metabolic heterogeneity, networks, and biomarkers of drug-induced liver injury. [PDF]

open access: yesJ Pharm Anal
Ding X   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy